Moderna's comments were released in briefing documents ahead of a Thursday meeting of the FDA's outside expert advisers to discuss the boos...

Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik.

Commending the government for its efforts to increase the vaccine availability in the country for achieving effective protection against CO...

Two rounds of high-level meetings chaired by the Cabinet Secretary were held last week on the availability of vaccines in the global as wel...

Talking about the tender, Uttar Pradesh government's Additional Chief Secretary Navneet Sehgal said the pre-bid meeting for it will be held...

"Moderna is being reviewed at the TAG (technical advisory group) meeting today," WHO spokesman Christian Lindmeier said in reply to a query...

Speaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to...

Following the green light from the European Medicines Agency (EMA), the final step is approval by the European Commission which is expected...

Germany will receive more than 130 million COVID-19 vaccine doses, enough for everybody, Health Minister Jens Spahn said on Wednesday, addi...

The meeting of the European Medicines Agency's human medicines committee (CHMP) comes amid high rates of infections in many EU countries an...

The meeting comes after the Pfizer-BioNTech vaccine received an emergency use authorization and the first three million doses were distribu...

FDA staff said a two-dose regimen of Moderna's vaccine was highly effective in preventing confirmed cases of COVID-19. The comments were ma...

"We have a data set of over 30,000 subjects who have been followed through the clinical trials. This gives us a very robust data set on whi...

The Food and Drug Administration is scheduled to hold the meeting on Dec. 17 to discuss the company’s request for emergency use authorisati...

In a statement the EU medicines regulator said it had already begun a ``rolling review'' of the vaccine based on laboratory data previously...

Moderna also reported a 100% success rate in preventing severe cases. The filing sets Moderna's product up to be the second vaccine likely ...

Moderna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet in...